Novel Spectacle Lenses for Myopia
(EUCALYPTUS Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications. However, if you are using any myopia control treatments like atropine, you would not be eligible to participate.
Research shows that impact-resistant spectacle lenses, especially those made from plastic materials, are effective in preventing eye injuries during activities with a risk of impact. This suggests that the lenses used in the trial may offer protective benefits, although their specific effectiveness in slowing myopia progression is not directly addressed in the provided studies.
12345Spectacle lenses are generally safe, but there is a small risk of eye injuries, especially during sports or high-impact activities. Using impact-resistant materials like polycarbonate can reduce this risk, and it's important to be cautious if you have certain eye conditions or a history of eye surgery.
13678The novel spectacle lenses for myopia are unique because they are designed to be impact-resistant, which means they are less likely to break or shatter compared to regular lenses. This feature makes them particularly suitable for individuals who engage in activities with a higher risk of eye injury, providing both vision correction and enhanced safety.
1291011Eligibility Criteria
This trial is for children aged 6-8 with mild to moderate near-sightedness (myopia) who have good vision with glasses and no more than a small difference in prescription between their eyes. They must be able to wear the study glasses at least 10 hours a day, not use contact lenses, and have no eye conditions or systemic diseases affecting vision.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single vision, impact-resistant spectacle lenses
Follow-up
Participants are monitored for safety and effectiveness after treatment